Pyrimidine analogues


Pyrimidine analogues
Pyrimidine analogues are a diverse group of drugs that inhibit production of pyrimidine nucleotides necessary for DNA synthesis. They include:
  • capecitabine
  • cytarabine
  • floxuridine
  • fluorouracil
  • gemcitabine.

Pharmacokinetics
Because pyrimidine analogues are poorly absorbed when they’re given orally, they’re usually administered by other routes.
 
Distribution, metabolism, and excretion
With the exception of cytarabine, pyrimidine analogues are well distributed throughout the body, including in cerebrospinal fluid (CSF). They’re metabolized extensively in the liver and are excreted in urine. Intrathecal cytarabine may be given with or without cranial radiation to treat CNS leukemia.
Pharmacodynamics
Pyrimidine analogues kill cancer cells by interfering with the natural function of pyrimidine nucleotides. 
 
Pharmacotherapeutics
Pyrimidine analogues may be used to treat many tumors. However, they’re primarily indicated in the treatment of:
  • acute leukemias
  • GI tract adenocarcinomas, such as colorectal, pancreatic, esophageal, and stomach adenocarcinomas
  • cancers of the breast and ovaries
  • malignant lymphomas.
Drug interactions
No significant drug interactions occur with most of the pyrimidine analogues; however, several drug interactions are possible with capecitabine.
  • Antacids, when given with capecitabine, may increase absorption of capecitabine.
  • Capecitabine can increase the pharmacodynamic effects of warfarin, thereby increasing the risk of bleeding.
  • Capecitabine may increase serum phenytoin levels.

Comments